Articles From: Neothetics Prices Initial Public Offering to Net Element to Bring Apple Pay to Merchants


SAN DIEGO, Nov.
Sign-up for Neothetics Prices Initial Public Offering investment picks
Neovasc Announces Treatment of First Patient in TIARA-I Clinical Trial Canada NewsWire NASDAQ: NVCN TSX: NVC VANCOUVER , Dec.
Sign-up for Neovasc Announces Treatment of First Patient in TIARA-I Clinical Trial investment picks
NASDAQ: NVCN TSX: NVC VANCOUVER , Dec.
Sign-up for Neovasc Announces Treatment of First Patient in TIARA-I Clinical Trial investment picks
NASDAQ: NVCN TSX: NVC VANCOUVER , Nov.
Sign-up for Neovasc to Present at Three Upcoming Investor Conferences in November investment picks
OPKO Health, Inc. (NYSE: OPK ) announced that its investee, Neovasc, has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate the U.S. arm of its TIARA-I Early Feasibility Trial for the Company’s Tiara™ transcatheter mitral valve.
Sign-up for Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve investment picks
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, announced today that it has closed on a $12 million term loan facility with East West Bank.
Sign-up for NephroGenex Announces Closing of $12 Million Term Loan Facility investment picks
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, will report its third quarter 2014 financial results on Wednesday, November 12, 2014 after the U.S. financial markets close.
Sign-up for NephroGenex Announces Date of Conference Call to Discuss Third Quarter 2014 Financial Results investment picks
NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced the appointment of Marco Taglietti, M.D., to its Board of Directors.
Sign-up for NephroGenex Appoints Marco Taglietti, M.D. to Board of Directors investment picks
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today reported financial results and business highlights for the third quarter ended September 30, 2014.
Sign-up for NephroGenex Reports Third Quarter 2014 Financial Results investment picks
NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer, Pierre Legault will present a corporate overview of the Company and meet with investors at the Bio-Europe ® 2014 healthcare conference in Frankfurt, Germany.
Sign-up for NephroGenex to Participate in Two Healthcare Conferences in November investment picks
NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Pierre Legault, Chief Executive Officer, will present a corporate overview of the Company and meet with investors at the 13 th annual Bio Investor Forum at the Palace Hotel in San Francisco.
Sign-up for NephroGenex to Present at the 13th Annual Bio Investor Forum investment picks
NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, announced the presentation of the novel design of its Phase 3 Pyridorin PIONEER clinical program at the American Society of Nephrology (ASN) Kidney Week meeting held here November 11-16, 2014.
Sign-up for NephroGenex, Inc. Announces Presentation at the American Society of Nephrology’s Kidney Week 2014 investment picks
Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, today provided an update on its operations and strategy.
Sign-up for Nephros Provides Corporate Update investment picks
LAVAL, Quebec, Oct.
Sign-up for Neptune and BlueOcean Sign Licensing Agreement investment picks
LAVAL, Quebec, Oct.
Sign-up for Neptune Announces Normal Course Issuer Bid investment picks
LAVAL, Quebec, Oct.
Sign-up for Neptune Announces Second Quarter Results investment picks
LAVAL, Quebec, Nov.
Sign-up for Neptune Completes Plant Ramp-Up investment picks
LAVAL, Quebec, Sept.
Sign-up for Neptune Reaches Annualized Production Capacity of 100 Metric Tons investment picks
LAVAL, Quebec, Oct.
Sign-up for Neptune Receives TSX Approval for Normal Course Issuer Bid investment picks
LAVAL, Quebec, Oct.
Sign-up for Neptune to Hold Conference Call to Discuss Second Quarter Results investment picks
LAVAL, Quebec, Sept.
Sign-up for Neptune to Present at Rodman & Renshaw Global Investment Conference investment picks
SAN JOSE, Calif.
Sign-up for NES Designed In MPS Industry First Monolithic 900V AC/DC Switching Regulator investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0977594001&sourceType=1 http://media3.marketwire.com/logos/20131010-20130129-Net1logful2.jpg JOHANNESBURG, SOUTH AFRICA --
Sign-up for Net 1 UEPS Technologies Inc. Reports First Quarter 2015 Results investment picks
Financing Will Allow Net Element to Accelerate its Growth Efforts in Russia MIAMI , Sept.
Sign-up for Net Element Announces $11 Million Financing from Alfa-Bank investment picks
Registration Statement is Intended to Provide the Company with Increased Financial Flexibility MIAMI , Oct.
Sign-up for Net Element Files $50 Million Universal Shelf Registration Statement investment picks
Transaction Provides Financial Flexibility, Strengthens Balance Sheet MIAMI , Sept.
Sign-up for Net Element Finalizes Debt Exchange Transaction with Crede Capital Group investment picks
Newly Released Platform Adds Offline Mode, Business Management and Analytics MIAMI , Nov.
Sign-up for Net Element Releases New Version of Aptito POS Platform investment picks
Open Letter to Shareholders Summarizes Recent Milestones MIAMI , Oct.
Sign-up for Net Element Releases Open Letter to Shareholders investment picks
Offering mobile payments so more customers can pay when, where and how they want MIAMI , Sept.
Sign-up for Net Element to Bring Apple Pay to Merchants investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Neothetics Prices Initial Public Offering to Net Element to Bring Apple Pay to Merchants
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent